https://ift.tt/eA8V8J The breast cancer drug lapatinib which is designed to shrink tumors can sometimes cause them to grow in the lab, according to a new study. By understanding the molecular basis of this phenomenon, scientists hope that their findings will lead to safer treatment decision-making and drug design in the future.
from https://ift.tt/2Fye1xy
via IFTTT
#1 Drug Treatment Center. Expert Medical Detox· Privacy & Safety · Caring & Compassionate CALL NOW 844-463-1889
GET HELP NOW
Subscribe to:
Post Comments (Atom)
Children whose mothers use marijuana are more likely to try it at younger age
When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...
-
New research raises the possibility that a wider group of people battling substance use disorders may benefit from a relapse-prevention comp...
-
http://ift.tt/eA8V8J A technique that measures tiny movements of the eyes may help scientists better understand and perhaps eventually impro...
-
http://ift.tt/eA8V8J Antibodies are proteins produced by the human immune system to ward off foreign invaders. Our bodies mount this defense...
No comments:
Post a Comment